Feasibility Trial of Pregnenolone for Posttraumatic Stress Disorder and Alcohol Use Disorder

NCT04464148 · clinicaltrials.gov ↗

PHASE1

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped Feasibility study was not initiated.

Conditions

Post Traumatic Stress Disorder
Alcohol Use Disorder

Interventions

DRUG: Pregnenolone 250 mg
DRUG: Pregnenolone 400 mg

Sponsor

University of Texas Southwestern Medical Center